Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Aselage Steve
Relationship:   Director
City:   Fremont
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   293,421    

Indirect Shares

   19,500      
Direct Value   $6,739,296    

Indirect Value

   $118,170      
Total Shares   312,921      
Total Value   $6,857,466      


Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $890,329 Biocryst Pharmaceuticals Inc $397,769 Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $890,329 Biocryst Pharmaceuticals Inc $397,769
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    4   
    5    

     Stock price went up :
    0   
    3    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   -4.0   
   1.5   
     Percentage Gain/Loss :
   -31.1%
 62.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Global Commercial... 2005-06-30 24,133 2004-08-03 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Business Of... 2012-07-02 59,030 2006-04-28 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2022-05-11 146,919 2021-11-05 19,500    Premium*  
            Acer Therapeutics Inc ACER Director 2023-11-17 0 2017-09-19 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2023-06-13 63,339 2019-03-12 0    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Ops   •       –      –    2006-10-31 4 B $6.92 $12,939 D/D 1,870 2,829 2.74 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2007-04-30 4 B $6.92 $14,295 D/D 2,066 4,895 2.74 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-04-30 4 B $10.37 $15,825 D/D 1,526 33,560 2.74 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2008-10-31 5 B $13.35 $16,506 D/D 1,236 32,401 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2009-10-31 5 B $11.60 $4,119 D/D 355 51,271 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-10-31 5 B $13.23 $2,658 D/D 201 46,679 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2013-08-15 4 B $4.50 $2,502 D/D 556 261,756 2.31 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2014-11-20 4 B $8.20 $10,660 D/D 1,300 363,056 2.81 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2014-11-21 4 B $8.50 $73,950 D/D 8,700 371,756 2.81 -
ACER Acer Therapeutics Inc Director   –       •      –    2017-12-14 4 B $12.00 $24,000 D/D 2,000 13,905 2.39 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2019-03-12 4 B $8.30 $16,600 D/D 2,000 2,000 2.39 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2019-05-22 4 B $3.57 $10,710 D/D 3,000 5,000 2.39 -
ACER Acer Therapeutics Inc Director   –       •      –    2019-07-03 4 B $3.72 $18,581 D/D 5,000 18,905 2.39 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2019-11-18 4 B $1.45 $21,750 D/D 15,000 21,672 2.39 -
ACER Acer Therapeutics Inc Director   –       •      –    2020-07-24 4 B $3.50 $157,500 D/D 45,000 63,905 2.39 %
ACER Acer Therapeutics Inc Director   –       •      –    2021-12-09 4 B $2.15 $4,334 D/D 2,016 65,921 2.31 %
ACER Acer Therapeutics Inc Director   –       •      –    2021-12-10 4 B $2.04 $16,287 D/D 7,984 73,905 2.39 %
ACER Acer Therapeutics Inc Director   –       •      –    2022-11-29 4 B $1.22 $500,000 D/D 409,836 483,741 2.39 %
CTIC Cti Biopharma Corporation EVP, Global Commercial Ops   •       –      –    2005-06-30 4 D $0.00 $0 D/D (106,667) 24,133 -
ACER Acer Therapeutics Inc Director   –       •      –    2023-11-17 4 D $0.00 $0 D/D (483,741) 0 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-02-04 4 GA $0.00 $0 I/I 25,000 25,000 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-07-16 4 GA $0.00 $0 I/I 3,000 28,000 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2015-09-11 4 GD $0.00 $0 D/D 3,000 368,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2016-01-27 4 GD $0.00 $0 D/D 3,000 305,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2016-11-21 4 GD $0.00 $0 D/D 57,000 248,756 0 -
  169  Records found
  1   2   3   4  5   6   7      
  Page 4 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us